Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis

Health Economics

Volumn 3, Issue 2, 1994, Pages 95-104

  Briggs, Andrew ^a   Sculpher, Mark ^a   Buxton, Martin ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Economic evaluation; health care technologies; sensitivity analysis; uncertainty

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HUMAN; REVIEW; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; HEALTH CARE COSTS; HUMAN; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0028398506     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.4730030206     Document Type: Article

References (45)

1. Needs assessment, priority setting, and contracts for health care: an economic view
2. Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada
3. A guide to the economic analysis of clinical practices
4. Economic evaluation of a support programme for caregivers of the demented elderly
5. Auronofin therapy and quality of life in patients with rheumatoid arthritis: results of a multicenter trial
6. An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia
7. Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B‐based therapies
8. Economic analysis alongside clinical trials: revisiting the methodological issues
9. Explanatory and pragmatic attitudes in therapeutic trials
10. Pragmatic versus explanatory trials
11. Variations in medical care among small areas
12. Variations in length of stay and outcome for six medical and surgical conditions in Massachusetts and California
13. Day‐case surgery for hernias and haemorrhoids: a clinical, social and economic evaluation
14. Reducing high blood cholesterol level with drugs: cost‐effectiveness of pharmacologic management
15. Cost‐effectiveness of low‐dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection
16. Standardizing methodologies for economic evaluation in health care
17. Discounting and health benefits
18. Discounting and health benefits: another perspective
19. Willingness to pay for publicly provided goods: a possible measure of benefit
20. The measurement of patients' valuesin medicine
21. Quality‐adjusted life years, utility theory and health‐years equivalents
22. Measurement of health state utilities for economic appraisal: a review
23. Measurement error in the Hawksley random zero sphygmomanometer: what damage has been done and what can we learn?
24. A cost‐effectiveness analysis of screening for hepatitis B surface antigen in India
25. Whether or not to administer amphotericin to an immunosup‐pressed patient with haematologic malignancy and undiagnosed fever
26. Cost‐effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease
27. A preliminary economic evaluation of the diode laser in ophthalmology
28. A relative cost‐effectiveness analysis of different methods of screening for diabetic retinopathy
29. Relative cost and cost‐effectiveness of extracorporeal shock‐wave lithotripsy versus percutaneous nephrolithotomy in the treatment of renal and ureteric stones
30. Variability among methods to assess patients' well‐being and consequent effect on a cost‐effectiveness analysis
31. Cost‐effectiveness analysis of end‐stage renal disease treatments
32. The threshold approach to clinical decision making
33. Comparison of different treatment strategies for diffuse large‐cell lymphomas: a decision analysis
34. Economic evaluation of ondansetron: preliminary analysis using clinical trial data prior to price setting
35. How attractive does a new technology have to be to warrant adoption and utilisation? Tentative guidelines for using clinical and economic evaluations
36. Probabilistic sensitivity analysis methods for general decision models
37. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach
38. Clinical importance, statistical significance and the assessment of economic and quality‐of‐life outcomes